Abstract
Peter H. Hwang: Speaker Bureau for Sanofi, Speakers Bureau and clinical trial funding for GlaxoSmithKline. All other authors declare no conflicts of interest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have